`
`From: Zolan, Alexander |mai|to:AZolan@wc.com|
`Sent: Wednesday, May 24, 2017 11:50 AM
`To: Steiner, Ellie
`Subject: RE: Xarelto - '218 patent
`
`Confirmed. Thanks.
`
`From: Steiner, Ellie |mailto:esteiner@wsgr.comI
`Sent: Wednesday, May 24, 2017 2:27 PM
`To: Zolan, Alexander <AZo|an wc.com>
`
`Subject: RE: Xarelto - '218 patent
`
`Alex,
`
`We will accept service via email on behalf of Mylan, effective today, provided we have confirmation from plaintiffs that
`
`doing so does not waive any objections or responses to the complaint other than insufficient service.
`
`Regards,
`Ellie
`
`From: Zolan, Alexander |mailto:AZolan@wc.com|
`Sent: Wednesday, May 24, 2017 7:20 AM
`To: Steiner, Ellie
`Subject: RE: Xarelto - '218 patent
`
`Thanks, Ellie. Please let me know today.
`
`From: Steiner, Ellie |mailto:esteiner@wsgr.comI
`Sent: Tuesday, May 23, 2017 12:33 PM
`
`To: Zolan, Alexander <AZo|an wc.com>
`
`Subject: RE: Xarelto - '218 patent
`
`Alex,
`
`I received your email and am looking into it. I will get back to you as soon as practicable.
`
`Regards,
`Ellie
`
`From: Zolan, Alexander |mailto:AZolan@wc.com|
`Sent: Monday, May 22, 2017 5:39 AM
`To: Steiner, Ellie
`Subject: Xarelto - '218 patent
`
`Ellie,
`
`MYLAN - EXHIBIT 1065
`
`MYLAN - EXHIBIT 1065
`
`
`
`
`We filed the attached complaint on Friday. Please let me know whether you will agree to accept service via email on
`behalf of Mylan. Thanks.
`
`Regards,
`Alex
`
`Alexander Zolan
`Williams & Connolly LLP
`725 Twelfth Street, N.W., Washington, DC 20005
`(P) 202-434-5208 | (F) 202-434-5029
`azolan@wc.com | www.wc.com/azolan
`
`
`
`
`This message and any attachments are intended only for the addressee and may contain information that is privileged and
`confidential. If you have received this message in error, please do not read, use, copy, distribute, or disclose the contents of the
`message and any attachments. Instead, please delete the message and any attachments and notify the sender immediately. Thank
`you.
`
`
`This email and any attachments thereto may contain private, confidential, and privileged material for the sole
`use of the intended recipient. Any review, copying, or distribution of this email (or any attachments thereto) by
`others is strictly prohibited. If you are not the intended recipient, please contact the sender immediately and
`permanently delete the original and any copies of this email and any attachments thereto.
`
`2
`
`